David J. Einstein, MD, Author at Grand Rounds in Urology

David J. Einstein, MD

Beth Israel Deaconess Medical Center

Boston, Massachusetts

David J. Einstein, MD, is a Genitourinary Medical Oncologist at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. Dr. Einstein also serves as an Assistant Professor of Medicine at Harvard Medical School in Boston. He specializes in cancer of the prostate, bladder, kidney, and testis. Dr. Einstein’s research focuses on immunotherapy and targeted approaches in prostate, bladder, and kidney cancers, with support from the Prostate Cancer Foundation,National Institutes of Health, Department of Defense, BIDMC, and industry partners.

Dr. Einstein earned a Bachelor’s in Science in Biology from Yale University in New Haven, Connecticut. He then earned his medical degree and completed a residency in Internal Medicine at Tufts Medical Center in Boston, Massachusetts. Afterward, Dr. Einstein completed a fellowship in Hematology and Oncology at the BIDMCin Boston, Massachusetts.

Dr. Einstein serves as a medical advisor to the Boston Prostate Cancer Support Group and the Massachusetts Prostate Cancer Coalition. He also serves as Principal Investigator of several Dana-Farber/Harvard Cancer Center (DF/HCC) clinical trials that investigate immune-based, targeted, and radioligand therapies for GU cancers. In addition, he is the Director of GU Oncology Clinical Research for the Beth Israel-Lahey Health network and Principal Investigator of the DF/HCC GU Rapid Autopsy program.

Talks by David J. Einstein, MD

Determining the Benefit of Therapy for Biochemically Recurrent Prostate Cancer

David J. Einstein, MD | Jan 2026

David Einstein, MD, reviews systemic therapy strategies and trial data in biochemical recurrent prostate cancer.